Valeant Pharmaceuticals International Inc said on Friday that it would increase the cash component in its takeover bid for Botox-maker Allergan Inc for the second time this week, contingent on the two sides negotiating. Valeant said it would pay $72 in cash - up from $58.30 on Wednesday - and 0.83 share of Valeant stock for each Allergan share.
Allergan, Inc. is a multi-specialty health care Company focused on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products. Shares of AGN traded higher by 5.19% or $8.22/share to $166.72. In the past year, the shares have traded as low as $81.33 and as high as $170.05. On average, 4361420 shares of AGN exchange hands on a given day and today's volume is recorded at 5533170.
Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX traded higher by 1.4% or $1.81/share to $131.03. In the past year, the shares have traded as low as $81.94 and as high as $153.10. On average, 3027590 shares of VRX exchange hands on a given day and today's volume is recorded at 8083145.
Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX traded higher by 1.48% or $2.08/share to $142.19. In the past year, the shares have traded as low as $83.39 and as high as $170.45. On average, 385702 shares of VRX.TO exchange hands on a given day and today's volume is recorded at 372095.
Source
